+ 1-971-202-1575 , TollFree:+ 1-800-910-6452
  [email protected]
Early Toxicity Testing Market by Technique (In vivo, In vitro, and In silico), End Users (Pharmaceuticals Industry, Diagnostics Industry, Food Industry, Chemicals Industry, Cosmetics Industry, and Other Industries) - Global Opportunity Analysis and Industry Forecast, 2014-2022
  • Published : May , 2017
  • |
  • Number of Pages : 220
  • |
  • Published By : Allied Market Research



Report Overview
In early toxicity testing, different techniques such as in vivo and in vitro are used to evaluate the adverse effects of the product on human health. Toxicity tests at early stage of drug development help reduce the risk of later stage failures. As the awareness regarding the welfare of human health and environment has increased, the stringency of regulatory approvals has also increased. As toxicity studies help assess the safety issue of the product, the increased stringency of the government regulators will help increase the adoption rate of toxicity techniques among the different companies. The global early toxicity testing market was $614 million in 2015 and is estimated to reach $1,012 million by 2022, registering a CAGR of 7.3% from 2016 to 2022.
Different types of tests such as neurotoxicity, acute toxicity tests, carcinogenicity, and systemic toxicity are conducted using in vivo and in vitro techniques. These tests help to verify if the product is safe for the human health and surrounding environment. Toxicity tests are used for wide variety of products such as cosmetics, food additives, chemicals, pesticides, drugs, and vaccines.
The global early toxicity testing market is attributed to the initiatives taken by the government to spend more on R&D of in vitro and in silico techniques due to the opposition of animal rights organization to use in vivo techniques for toxicity tests. The advancement in in vitro and in silico techniques will positively impact the market growth. However, lack of awareness regarding the benefits of using early toxicity testing among the companies and limitations of preclinical testing are expected to hamper the growth of the global early toxicity testing market.
EARLY TOXICITY TESTING MARKET KEY BENEFITS

This report entails detailed quantitative analysis of the current market trends for the period of 2014-2022 to identify the prevailing opportunities.
The market estimations provided in the report are based on comprehensive analysis of the key developments in the industry.
The global early toxicity testing market is comprehensively analyzed with respect to technique, end users, and geography.
In-depth analysis based on geography helps understand the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

EARLY TOXICITY TESTING MARKET KEY SEGMENTS:
By Technique

In Vivo
In Vitro


By Assay



Enzyme Toxicity Assays

Bacterial Toxicity Assays

Cell-Based ELISA and Western Blots

Tissues Culture Assays

Receptor Binding Assays

Other Assays




By Toxicity End-points



Dermal Toxicity

Systemic Toxicity

Carcinogenicity

Ocular Toxicity

Skin Sensitization and Irritation

Genotoxicity

Neurotoxicity

Organ Toxicity

Other Toxicity Endpoints and Tests





In silico

By End Users

Pharmaceuticals industry
Diagnostics industry
Food industry
Chemicals industry
Cosmetics industry
Other industries

By Geography

North America


U.S.

Canada

Mexico


Europe


Germany

UK

France

Rest of Europe


Asia-Pacific


Japan

China

Australia

India

Rest of Asia-Pacific


LAMEA


Brazil

Republic of South Africa

Rest of LAMEA



The key players profiled in this report include:

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies Inc.
Quest Diagnostics Incorporation
Merck & Co., Inc.
Charles River Laboratories International Incorporation
Becton, Dickinson And Company
Danaher Corporation
Evotec Ag
The Jackson Laboratory

The other players of the early toxicity testing market include (companies not profiled in the report):

Covance
CellSystems
BioQuanta
Epithelix
Celther Polska
HemoGenix



Similar Market Studies

PUBLISHED REPORTS


UPCOMING REPORTS


Reports and Intelligence


We Accept

  • Stay Connected

Copyright ©2017 Reportsandintelligence All Rights Reserved